Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_assertion type Assertion NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_head.
- NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_assertion wasGeneratedBy ECO_0000203 NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_provenance.
- NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_assertion wasDerivedFrom befree-2016 NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_provenance.
- NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_assertion SIO_000772 24011934 NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_provenance.
- NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_assertion evidence source_evidence_literature NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_provenance.
- NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_assertion description "[These studies identify dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective new approach to treating ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108220.RABO6Lz_X_iYpoFjkaRJaBC8_C74RGwkISzTSSgY87PHA130_provenance.